Departamento académico
(FM) Oncología
Publications (56) Publications in which a researcher has participated
2018
-
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
Cell, Vol. 175, Núm. 2, pp. 313-326
-
A dormant TIL phenotype defines non-small cell lung carcinomas sensitive to immune checkpoint blockers
Nature Communications, Vol. 9, Núm. 1
-
A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients
Journal of Pathology, Vol. 245, Núm. 4, pp. 421-432
-
A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis
Journal for ImmunoTherapy of Cancer, Vol. 6, Núm. 1
-
Adjuvant therapy for colon cancer: Genes, genes. . . And the patient in the center
Clinical Cancer Research, Vol. 24, Núm. 16, pp. 3787-3789
-
Are phase I trials safe for older patients?
Journal of Geriatric Oncology, Vol. 9, Núm. 2, pp. 87-92
-
Association between PD1 mRNA and response to anti-PD1 monotherapy across multiple cancer types
Annals of Oncology, Vol. 29, Núm. 10, pp. 2121-2128
-
Atezolizumab in Platinum-treated Locally Advanced or Metastatic Urothelial Carcinoma: Outcomes by Prior Number of Regimens
European Urology, Vol. 73, Núm. 3, pp. 462-468
-
Characterization of Macrophage Endogenous S-Nitrosoproteome Using a Cysteine-Specific Phosphonate Adaptable Tag in Combination with TiO2 Chromatography
Journal of Proteome Research, Vol. 17, Núm. 3, pp. 1172-1182
-
Circulating Tumor Cells as a Biomarker of Survival and Response to Radium-223 Therapy: Experience in a Cohort of Patients With Metastatic Castration-Resistant Prostate Cancer
Clinical Genitourinary Cancer, Vol. 16, Núm. 6, pp. e1133-e1139
-
Combination of pegylated liposomal doxorubicin plus gemcitabine in heavily pretreated metastatic breast cancer patients: Long-term results from a single institution experience
Breast Journal, Vol. 24, Núm. 4, pp. 473-479
-
Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients
Annals of Oncology, Vol. 29, Núm. 5, pp. 1312-1319
-
Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB)
OncoImmunology, Vol. 7, Núm. 1
-
Early evolutionary divergence between papillary and anaplastic thyroid cancers
Annals of Oncology, Vol. 29, Núm. 6, pp. 1454-1460
-
Early-drug development in the era of immuno-oncology: Are we ready to face the challenges?
Annals of Oncology, Vol. 29, Núm. 8, pp. 1727-1740
-
Effect of Primary Tumor Side on Survival Outcomes in Untreated Patients With Metastatic Colorectal Cancer When Selective Internal Radiation Therapy Is Added to Chemotherapy: Combined Analysis of Two Randomized Controlled Studies
Clinical Colorectal Cancer, Vol. 17, Núm. 4, pp. e617-e629
-
Ent cobra ontology: the covariates classification system proposed by the Head & Neck and Skin GEC-ESTRO Working Group for interdisciplinary standardized data collection in head and neck patient cohorts treated with interventional radiotherapy (brachytherapy)
Journal of Contemporary Brachytherapy, Vol. 10, Núm. 3, pp. 260-266
-
Evaluating trifluridine + tipiracil hydrochloride in a fixed combination (TAS-102) for the treatment of colorectal cancer
Expert Opinion on Pharmacotherapy, Vol. 19, Núm. 6, pp. 623-629
-
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer
Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483
-
High-throughput 3-dimensional culture of epithelial ovarian cancer cells as preclinical model of disease
Oncotarget, Vol. 9, Núm. 31, pp. 21893-21903